{
    "2021-08-11": [
        [
            {
                "time": "",
                "original_text": "康泰生物13价肺炎疫苗入局，“黄金单品”还剩多少空间？",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎疫苗",
                        "黄金单品"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-08-11",
                "original_text": "A股资金流向（8月11日）：锂电上游龙头强者恒强",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "锂电",
                        "上游",
                        "龙头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "锂电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【行情】抗病毒概念股持续走低，康希诺跌超7%，万泰生物、复星医药跌逾5%，沃森生物、泰林生物、谱尼测试等跟跌",
                "features": {
                    "keywords": [
                        "抗病毒",
                        "康希诺",
                        "万泰生物",
                        "复星医药",
                        "沃森生物",
                        "泰林生物",
                        "谱尼测试"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药板块开启震荡调整，这两只医药股市值逆势增长超百亿元",
                "features": {
                    "keywords": [
                        "医药板块",
                        "震荡调整",
                        "市值增长"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-08-10",
                "original_text": "A股融资融券日报：两融余额增加29.47亿元（8月10日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场资金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "市场格局加速重塑，谁将成为中国的“疫苗之王”？",
                "features": {
                    "keywords": [
                        "市场格局",
                        "疫苗之王"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}